SE450665B - Nukleolera antigener fran cancerceller, framstellning av motsvarande antikroppar och reagenslosning innehallande merkta antikroppar - Google Patents

Nukleolera antigener fran cancerceller, framstellning av motsvarande antikroppar och reagenslosning innehallande merkta antikroppar

Info

Publication number
SE450665B
SE450665B SE8100011A SE8100011A SE450665B SE 450665 B SE450665 B SE 450665B SE 8100011 A SE8100011 A SE 8100011A SE 8100011 A SE8100011 A SE 8100011A SE 450665 B SE450665 B SE 450665B
Authority
SE
Sweden
Prior art keywords
antigens
antibodies
nucleolar
cells
cancer cells
Prior art date
Application number
SE8100011A
Other languages
English (en)
Swedish (sv)
Other versions
SE8100011L (sv
Inventor
H Busch
R K Busch
F Gyorkey
P Gyorkey
F M Davis
K Smetana
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of SE8100011L publication Critical patent/SE8100011L/
Publication of SE450665B publication Critical patent/SE450665B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
SE8100011A 1980-01-04 1981-01-02 Nukleolera antigener fran cancerceller, framstellning av motsvarande antikroppar och reagenslosning innehallande merkta antikroppar SE450665B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000343088A CA1157373A (en) 1980-01-04 1980-01-04 Detection of human cancer cells with antibodies to human cancer nucleolar antigen(s)

Publications (2)

Publication Number Publication Date
SE8100011L SE8100011L (sv) 1981-07-05
SE450665B true SE450665B (sv) 1987-07-13

Family

ID=4115973

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8100011A SE450665B (sv) 1980-01-04 1981-01-02 Nukleolera antigener fran cancerceller, framstellning av motsvarande antikroppar och reagenslosning innehallande merkta antikroppar

Country Status (27)

Country Link
JP (1) JPS56101553A (it)
KR (1) KR850001770B1 (it)
AR (1) AR232046A1 (it)
AT (1) AT373397B (it)
AU (1) AU535024B2 (it)
BE (1) BE886935A (it)
CA (1) CA1157373A (it)
CH (1) CH659328A5 (it)
DE (1) DE3047654A1 (it)
DK (1) DK554980A (it)
ES (2) ES8206855A1 (it)
FI (1) FI810007L (it)
FR (1) FR2484650B1 (it)
GB (1) GB2067286B (it)
GR (1) GR72850B (it)
IE (1) IE50760B1 (it)
IL (1) IL61641A (it)
IT (1) IT1172216B (it)
LU (1) LU83015A1 (it)
NL (1) NL8007128A (it)
NO (2) NO803910L (it)
NZ (1) NZ195756A (it)
OA (1) OA06713A (it)
PH (5) PH18765A (it)
PT (1) PT72301B (it)
SE (1) SE450665B (it)
ZA (1) ZA807754B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487830A (en) * 1982-05-14 1984-12-11 American Hoechst Corporation Enzyme/immunofluorescent assay for autoantibodies
JPS5990052A (ja) * 1982-11-16 1984-05-24 Katsu Taniguchi モノクロ−ナル特異抗体を用いたメラノ−マ診断薬
EP0145373B1 (en) * 1983-11-23 1992-03-25 The Ohio State University Research Foundation Purification of cancer-associated protein and preparation of antibody thereto
US4871661A (en) * 1983-11-23 1989-10-03 The Ohio State University Research Foundation Process for testing the carcinogenicity of a material or the presence of cancer-inducing factors in an environment
US4746539A (en) * 1983-11-23 1988-05-24 The Ohio State University Research Foundation Purification of cancer-associated protein and preparation of antibody thereto
US4645737A (en) * 1984-03-05 1987-02-24 American Hoechst Corporation Enzyme/immunofluorescent assay for anti-treponemal antibodies
US4607008A (en) * 1984-03-05 1986-08-19 American Hoechst Corporation Enzyme/immunofluorescent assay for anti-Epstein-Barr Virus antibodies
EP0162977B1 (en) * 1984-05-02 1992-05-20 University Research Corporation Enzyme immunoassay for cancer procoagulant
US4616658A (en) * 1985-02-27 1986-10-14 William Shell Non-radioactively labeled microspheres and use of same to measure blood flow
US4798719A (en) * 1986-09-11 1989-01-17 University Of Pittsburgh Method for selection of antigens suitable as in vivo targets for antibodies
US5019368A (en) * 1989-02-23 1991-05-28 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
US4861581A (en) * 1986-12-05 1989-08-29 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
CA2023030A1 (en) * 1990-07-13 1992-01-14 Robert R. Guerrero In vitro method and probe for detecting the presence of the ring shaped particle and malignancy in humans and animals

Also Published As

Publication number Publication date
PH18765A (en) 1985-09-20
PT72301B (en) 1981-11-10
IE802533L (en) 1981-07-04
ES498305A0 (es) 1982-08-01
CH659328A5 (de) 1987-01-15
IL61641A0 (en) 1981-01-30
AT373397B (de) 1984-01-10
KR850001770B1 (ko) 1985-12-18
KR830003898A (ko) 1983-06-30
BE886935A (fr) 1981-04-16
ATA1081A (de) 1983-05-15
GB2067286A (en) 1981-07-22
SE8100011L (sv) 1981-07-05
PH18637A (en) 1985-08-23
NO803910L (no) 1981-07-06
AR232046A1 (es) 1985-04-30
JPS56101553A (en) 1981-08-14
IL61641A (en) 1984-03-30
PH18624A (en) 1985-08-21
NL8007128A (nl) 1981-08-03
IT1172216B (it) 1987-06-18
PH18636A (en) 1985-08-23
ES8206855A1 (es) 1982-08-01
FR2484650B1 (fr) 1985-06-21
IT8167001A0 (it) 1981-01-05
LU83015A1 (fr) 1981-06-04
ZA807754B (en) 1982-02-24
DK554980A (da) 1981-07-05
DE3047654C2 (it) 1990-12-20
NO850005L (no) 1981-07-06
PH18129A (en) 1985-03-22
FR2484650A1 (fr) 1981-12-18
IE50760B1 (en) 1986-07-09
PT72301A (en) 1981-01-01
CA1157373A (en) 1983-11-22
NZ195756A (en) 1983-11-18
ES509239A0 (es) 1983-06-16
AU6507080A (en) 1981-07-09
DE3047654A1 (de) 1981-09-10
ES8307377A1 (es) 1983-06-16
OA06713A (fr) 1982-06-30
GB2067286B (en) 1984-01-04
FI810007L (fi) 1981-07-05
AU535024B2 (en) 1984-03-01
GR72850B (it) 1983-12-07

Similar Documents

Publication Publication Date Title
Foster et al. Monoclonal antibodies to the human mammary gland: I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues
Epstein et al. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Battifora et al. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach
Koffler et al. Immunological studies concerning the nephritis of systemic lupus erythematosus
Hijmans et al. An immunofluorescence procedure for the detection of intracellular immunoglobulins
Nuti et al. A monoclonal antibody (B72. 3) defines patterns of distribution of a novel tumor‐associated antigen in human mammary carcinoma cell populations
Stacker et al. A new breast carcinoma antigen defined by a monoclonal antibody
SE450665B (sv) Nukleolera antigener fran cancerceller, framstellning av motsvarande antikroppar och reagenslosning innehallande merkta antikroppar
FI85814C (fi) Foerfarande foer producering av en monoklonal antikropp foer humana icke-litencellslungcancer.
Cullen et al. The distribution of alloantigenic specificities of native H-2 products
US4448890A (en) Detection of human cancer cells with antibodies to human cancer nucleolar antigens
Biberfeld et al. Surface immunoglobulin light chain determinants on normal and PHA-stimulated human blood lymphocytes studied by immunofluorescence and electronmicroscopy
Keydar et al. Detection of viral proteins in mouse mammary tumors by immunoperoxidase staining of paraffin sections.
WO1987004183A1 (en) Murine hybridoma and diagnostic antibody produced thereby
US4782015A (en) Method for determining the presence of malignant cells
CA1233774A (en) Monoclonal antibody to small cell carcinoma cells
JP2555028B2 (ja) ヒト非−小細胞肺癌に関するモノクロ−ナル抗体
CA1320689C (en) Monoclonal antibody specific for human basal cell surface antigen
US4794077A (en) Detection of human cancer cells with anitbodies to human cancer nucleolar antigen p145
Sulitzeanu Antigenic components of rat connective tissue.
Chester et al. An analysis of immunocomplexes for the detection of the early stages of colon cancer
McCoy et al. Tumor-bound immunoglobulin in human gynecologic cancers
CA1172165A (en) Detection of human cancer cells with antibodies to human cancer nucleolar antegen(s)
Davis et al. Human malignancy-associated nucleolar antigen as a marker for tumor cells in patients with acute leukemia
PAPSIDERO et al. Hybridoma antibody to breast cancer immune complexes

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8100011-9

Effective date: 19910805

Format of ref document f/p: F